Regulation of alternative splicing of tau exon 10 by 9G8 and Dyrk1A

Neurobiology of Aging

Volumn 33, Issue 7, 2012, Pages 1389-1399

  Ding, Shaohong ^a   Shi, Jianhua ^a,b   Qian, Wei ^a   Iqbal, Khalid ^b   Grundke Iqbal, Inge ^b   Gong, Cheng Xin ^b   Liu, Fei ^a,b  

^a NANTONG UNIVERSITY   (China)

^b NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

9G8; Alternative splicing; Dyrk1A; Neurodegeneration; Tau

Indexed keywords

PROTEIN KINASE; REGULATOR PROTEIN; SPLICING FACTOR 9G8; TAU PROTEIN; TYROSINE PHOSPHORYLATION REGULATED KINASE 1A; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; AMINO ACID COMPOSITION; ANIMAL CELL; ARTICLE; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SPECIFICITY; EXON; GENE ACTIVITY; GENE INTERACTION; GENE LOCATION; HUMAN; HUMAN CELL; NEUROPATHOLOGY; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; EXONS; HEK293 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RATS; RNA-BINDING PROTEINS; TAU PROTEINS;

EID: 84861190576     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.11.021     Document Type: Article

References (35)

1. Andreadis A. Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. Biochim. Biophys. Acta 2005, 1739:91-103.
2. Andreadis A., Brown W.M., Kosik K.S. Structure and novel exons of the human tau gene. Biochemistry 1992, 31:10626-10633.
3. Bain J., Plater L., Elliott M., Shpiro N., Hastie C.J., McLauchlan H., Klevernic I., Arthur J.S., Alessi D.R., Cohen P. The selectivity of protein kinase inhibitors: a further update. Biochem. J 2007, 408:297-315.
4. Ballatore C., Lee V.M., Trojanowski J.Q. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci 2007, 8:663-672.
5. Blaustein M., Pelisch F., Tanos T., Munoz M.J., Wengier D., Quadrana L., Sanford J.R., Muschietti J.P., Kornblihtt A.R., Caceres J.F., Coso O.A., Srebrow A. Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT. Nat. Struct. Mol. Biol 2005, 12:1037-1044.
6. Chen-Hwang M.C., Chen H.R., Elzinga M., Hwang Y.W. Dynamin is a minibrain kinase/dual specificity Yak1-related kinase 1A substrate. J. Biol. Chem 2002, 277:17597-17604.
7. Colwill K., Feng L.L., Yeakley J.M., Gish G.D., Caceres J.F., Pawson T., Fu X.D. SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors. J. Biol. Chem 1996, 271:24569-24575.
8. Colwill K., Pawson T., Andrews B., Prasad J., Manley J.L., Bell J.C., Duncan P.I. The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution. EMBO J 1996, 15:265-275.
9. D'Souza I., Poorkaj P., Hong M., Nochlin D., Lee V.M., Bird T.D., Schellenberg G.D. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc. Natl. Acad. Sci. U. S. A 1999, 96:5598-5603.
10. D'Souza I., Schellenberg G.D. Regulation of tau isoform expression and dementia. Biochim. Biophys. Acta 2005, 1739:104-115.
11. Dreyfuss G., Kim V.N., Kataoka N. Messenger-RNA-binding proteins and the messages they carry. Nat. Rev. Mol. Cell Biol 2002, 3:195-205.
12. Gao L., Wang J., Wang Y., Andreadis A. SR protein 9G8 modulates splicing of tau exon 10 via its proximal downstream intron, a clustering region for frontotemporal dementia mutations. Mol. Cell. Neurosci 2007, 34:48-58.
13. Gao Q.S., Memmott J., Lafyatis R., Stamm S., Screaton G., Andreadis A. Complex regulation of tau exon 10, whose missplicing causes frontotemporal dementia. J. Neurochem 2000, 74:490-500.
14. Goedert M., Jakes R. Mutations causing neurodegenerative tauopathies. Biochim. Biophys. Acta 2005, 1739:240-250.
15. Goedert M., Spillantini M.G., Jakes R., Rutherford D., Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 1989, 3:519-526.
16. Gotz J., Probst A., Spillantini M.G., Schafer T., Jakes R., Burki K., Goedert M. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J 1995, 14:1304-1313.
17. Graveley B.R. Sorting out the complexity of SR protein functions. RNA 2000, 6:1197-1211.
18. Grover A., Houlden H., Baker M., Adamson J., Lewis J., Prihar G., Pickering-Brown S., Duff K., Hutton M. 5' splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10. J. Biol. Chem 1999, 274:15134-15143.
19. Grundke-Iqbal I., Iqbal K., Quinlan M., Tung Y.C., Zaidi M.S., Wisniewski H.M. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem 1986, 261:6084-6089.
20. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U. S. A 1986, 83:4913-4917.
21. Gui J.F., Tronchere H., Chandler S.D., Fu X.D. Purification and characterization of a kinase specific for the serine- and arginine-rich pre-mRNA splicing factors. Proc. Natl. Acad. Sci. U. S. A 1994, 91:10824-10828.
22. Guimera J., Casas C., Estivill X., Pritchard M. Human minibrain homologue (MNBH/DYRK1): characterization, alternative splicing, differential tissue expression, and overexpression in Down syndrome. Genomics 1999, 57:407-418.
23. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R.C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J.M., Nowotny P., Che L.K., Norton J., Morris J.C., Reed L.A., Trojanowski J., Basun H., Lannfelt L., Neystat M., Fahn S., Dark F., Tannenberg T., Dodd P.R., Hayward N., Kwok J.B., Schofield P.R., Andreadis A., Snowden J., Craufurd D., Neary D., Owen F., Oostra B.A., Hardy J., Goate A., van Swieten J., Mann D., Lynch T., Heutink P. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998, 393:702-705.
24. Ishihara T., Hong M., Zhang B., Nakagawa Y., Lee M.K., Trojanowski J.Q., Lee V.M. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 1999, 24:751-762.
25. Kosik K.S., Orecchio L.D., Bakalis S., Neve R.L. Developmentally regulated expression of specific tau sequences. Neuron 1989, 2:1389-1397.
26. Liu F., Gong C.X. Tau exon 10 alternative splicing and tauopathies. Mol. Neurodegener 2008, 3:8.
27. Liu F., Liang Z., Wegiel J., Hwang Y.W., Iqbal K., Grundke-Iqbal I., Ramakrishna N., Gong C.X. Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome. FASEB J 2008, 22:3224-3233.
28. Rossi F., Labourier E., Forne T., Divita G., Derancourt J., Riou J.F., Antoine E., Cathala G., Brunel C., Tazi J. Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I. Nature 1996, 381:80-82.
29. Shi J., Zhang T., Zhou C., Chohan M.O., Gu X., Wegiel J., Zhou J., Hwang Y.W., Iqbal K., Grundke-Iqbal I., Gong C.X., Liu F. Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome. J. Biol. Chem 2008, 283:28660-28669.
30. Stanford P.M., Shepherd C.E., Halliday G.M., Brooks W.S., Schofield P.W., Brodaty H., Martins R.N., Kwok J.B., Schofield P.R. Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia. Brain 2003, 126:814-826.
31. Swartz J.E., Bor Y.C., Misawa Y., Rekosh D., Hammarskjold M.L. The shuttling SR protein 9G8 plays a role in translation of unspliced mRNA containing a constitutive transport element. J. Biol. Chem 2007, 282:19844-19853.
32. Wang J., Xiao S.H., Manley J.L. Genetic analysis of the SR protein ASF/SF2: interchangeability of RS domains and negative control of splicing. Genes Dev 1998, 12:2222-2233.
33. Wegiel J., Imaki H., Wang K.C., Wegiel J., Rubenstein R. Cells of monocyte/microglial lineage are involved in both microvessel amyloidosis and fibrillar plaque formation in APPsw tg mice. Brain Res 2004, 1022:19-29.
34. Wolfe M.S. Tau mutations in neurodegenerative diseases. J. Biol. Chem 2009, 284:6021-6025.
35. Yu Q., Guo J., Zhou J. A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10. J. Neurochem 2004, 90:164-172.